Katie is a Research Officer under the Viral Hepatitis Elimination Program, working on improving treatment access for hepatitis C. Her interests are health equity & economics, infectious disease epidemiology and health policy. Her research approach is interdisciplinary, using a combination of mathematical modelling and empirical work.
Katie is a consultant for the World Health Organization, developing tools and policy for national strategic planning in maternal and child health. Katie also works on health economics in relation to HIV, hepatitis C and tuberculosis treatment, and on vector-borne disease control.
- 2020 - ongoing - Research Officer, Burnet Institute, Melbourne, Australia
- 2018 - ongoing - Consultant, World Health Organization, Department of Reproductive Health & Research, Geneva, Switzerland
- 2018 - 2018 - Environmental Scientist, Instituto Nacional de Pesquisas Espaciais (INPE), São José dos Campos, Brazil
- 2016 - Scientific Enterprise Consultant, The Nasio Trust, Musanda, Western, Kenya
- 2014 - 2015 - Research Officer, International Prevention Research Institute (IPRI), Lyon, France
- 2012 - Research Assistant, University of Strathclyde, Department of Mathematics and Statistics, Glasgow, UK
- 2019 - PhD Zoology, University of Oxford
- 2014 - MSc Epidemiology, Imperial College London
- 2013 - BA Philosophy, University of Cambridge
The elimination of hepatitis C as a global public health threat
The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19
The QuickStart Study
- Reaching UNAIDS 95-95-95 targets worldwide: predicted benefits and treatment costs with generic manufacture.
Heath K, Levi J, Hill A
AIDS. 2021 Jun; Epub ahead of print
- The Optimise Study: Social networks and mixing patterns. (PUBLIC HEALTH REPORT)
Saich F, Heath K, Altermatt A, Munari S, Merner B, Hill S, Lusher D, Radhitio Sadewo G, Wang P, Pedrana A, Gibney K, Hellard M
The Optimise Study. 2021 Apr; Report 5:1-12
News Articles (1)